Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History
December 11, 2025
Endpoints News is calling December 10 the busiest day ever in biotech, with the most follow-on proceeds in a single day. A record-setting $3.2B in biotech follow-on stock offerings were sold, indicating public investors’ appetite for biotech investment. From late Tuesday evening into Wednesday morning, eight biotechs priced sales of new stocks, and seven of those companies increased their offering sizes to meet demand.
Utah’s own Denali Therapeutics was among the biotechs raising funds.
Recent News
- BioUtah Member Appreciation BBQ 2026 Recap
- Epitel Adds Proven Medtech Leader James Reinstein to Board As Company Enters Next Stage of Growth
- Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression
- CLENE ANNOUNCES $4 MILLION REGISTERED DIRECT OFFERING
- Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola
- Myriad Genetics Appoints Vishal Sikri Executive Vice President – Commercial
